Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/21776
Title: Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy.
Authors: 
Mesh: 
Issue Date: 1-Sep-2015
Citation: Clin. Cancer Res..2015 Sep;(21)17:3995-4003
Abstract: To investigate the direct effect and therapeutic consequences of epidermal growth factor receptor 2 (HER2)-targeting therapy on expression of estrogen receptor (ER) and Bcl2 in preclinical models and clinical tumor samples.
PMID: 26015514
URI: https://hdl.handle.net/20.500.12530/21776
Rights: openAccess
ISSN: 1078-0432
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. General U. Gregorio Marañón > Artículos

Files in This Item:
File Description SizeFormat 
PMC4558260.pdf754.35 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.